Explore Stanford technologies available for licensing:

Researchers at Stanford University have identified EP300 modulators as effective treatments for reducing skin scarring, demonstrating significant regeneration of hair follicles, sweat glands, and connective tissue architecture.

Scientists in Dr. Howard Chang's lab have developed ESCAPE-seq (Enhanced Single Chain Antigen Presentation sequencing) to identify novel neoantigen sequences for the development of immunotherapies.

PirB (PIR-B) knockout mice are genetically modified mice in which the gene encoding the PirB receptor (paired immunoglobulin-like receptor B) has been disrupted or "knocked out." PirB is a member of the immunoglobulin superfamily and plays a role in regulating immune responses

Stanford researchers have developed a label-free assay to detect protein aggregation and established a proof of concept in α-synuclein aggregates.

Stanford researchers have developed a method for screening RNA-modulating drugs that reports on changes to mRNA in its native cellular context.

Stanford scientists have developed a method incorporating Hall-effect sensors and machine learning models to localize partial discharge for insulation defect detection and reliability assessment.

Researchers from Stanford's Space Rendezvous Lab are developing a software codebase to facilitate high-fidelity spacecraft control simulations.

Stanford researchers have developed a groundbreaking universal programmable and self-configuring optical filter.

As the demand for faster internet, improved bandwidth, and enhanced data security grows, researchers from Stanford and Aalto University have introduced metacrystals—a novel class of passive intelligent surfaces designed to revolutionize wireless communication.

Stanford researchers have developed a scalable, fully human in vitro system for more accurately modeling human adaptive immune responses.

Stanford inventors have developed an optimal strain sensing network for continuous monitoring of cardiac strains to monitor cardiac health and assess real-time response to therapies.

Stanford researchers have developed a conductive nanoporous powder technology that dramatically enhances electrode stability and efficiency for fuel cells and electrolyzers.

Stanford researchers have developed the first ex vivo bone marrow niche capable of sustaining normal and diseased hematopoietic cells long-term.

Stanford scientists have developed a novel microneedle array system that rapidly collects dermal interstitial fluid for diagnostic applications.

Stanford doctors have developed an innovative left ventricular decompression vent with multiple-channels design that significantly enhances blood removal during cardiac surgery.